Market Study -Myocardial Infarction Pipeline Review, H1 Market Analysis and Causes Report 2016 by Radiant Insights, Inc

Myocardial Infarction Market Share, Analysis and
Causes, Pipeline Review, H1 2016
Myocardial Infarction - Pipeline Review, H1 2016
Summary
Global Markets Direct's, ‘Myocardial Infarction - Pipeline Review, H1 2016', provides an overview of the
Myocardial Infarction pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Myocardial
Infarction, complete with analysis by stage of development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological
action of the therapeutics, its complete research and development history and latest news and press
releases. Additionally, the report provides an overview of key players involved in therapeutic
development for Myocardial Infarction and features dormant and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic
review following a stringent set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
Read Complete Report With TOC @ http://www.radiantinsights.com/research/myocardial-infarctionpipeline-review-h1-2016
The report helps in identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter strategies to gain
competitive advantage.
Note*:...